Ma. Warmuth et al., A REVIEW OF HEREDITARY BREAST-CANCER - FROM SCREENING TO RISK FACTOR MODIFICATION, The American journal of medicine, 102(4), 1997, pp. 407-415
The identification of genetic mutations thought to be directly respons
ible for the development of breast cancer represents a major advance i
n our understanding of this disease. Mutations in BRCA1 and BRCA2 are
thought to be responsible for the majority of inherited breast cancer.
Although these mutations account for approximately 5% of breast cance
r cases, the identification of these genes will have a profound impact
on the way patients and their physicians view breast cancer risk. Gen
etic testing for BRCA1 and BRCA2 mutations is already available. Inter
preting results of genetic tests for these mutations is problematic an
d the clinical management of women carrying these gene mutations is fa
r from straightforward. The purpose of this paper is to review recent
developments in the genetic aspects of breast cancer, including geneti
c testing, to critically review risk factor modification, and to discu
ss screening and potential prophylactic measures. (C) 1997 by Excerpta
Medica, Inc.